Skip to main content
Article thumbnail
Location of Repository

Controlling Hypertension: Education & Empowerment Renal Study (C.H.E.E.R.S)

By Jo Byrne

Abstract

The author previously published under the name of Jo Mason.The overall aim of the programme of work in this thesis was to contribute to the development of effective patient education for BP control in people with chronic kidney disease (CKD). Specific objectives of the thesis were:\ud 1. To define the problem of BP control in our local CKD population by conducting a cross-sectional investigation.\ud 2. To conduct a systematic review of randomised controlled trials (RCTs) evaluating educational interventions in kidney disease care, in order to establish the effectiveness of patient education based on patient empowerment and to set out key recommendations for the development and evaluation of good quality educational interventions.\ud 3. To develop a structured educational intervention designed to be realistic and practical within the context of a busy renal department involving:\ud a. identification of suitable theories and evidence and\ud b. identification and exploration of patients’ and health professionals’ needs regarding BP control, using focus groups.\ud 4. To test the hypothesis that implementation of an educational intervention would lead to improved BP control, by conducting an exploratory RCT comparing standard clinical care for BP management with standard care supplemented by the educational intervention.\ud Key findings showed:\ud • A need for education with less than half our CKD population with BP to target.\ud • Limited evidence is available evaluating the effectiveness of patient education in kidney disease care and the current literature lacks rigorous study design and reporting.\ud • Patient confusion is a key issue that needs to be addressed.\ud • The effective delivery and evaluation of education to promote BP control in people with CKD requires increased patient awareness and involvement.\ud The findings from this programme of research are used to provide evidence for recommendations to improve future research and clinical management to promote better BP control in people with CKD

Publisher: University of Leicester
Year: 2010
OAI identifier: oai:lra.le.ac.uk:2381/8329

Suggested articles

Citations

  1. (2009). [Epidemiology and etiology of therapyresistant hypertension]",
  2. (1994). A case-management system for coronary risk factor modification after acute myocardial infarction",
  3. (2005). A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trial", -
  4. (2010). A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study",
  5. (2003). A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients",
  6. (2005). A report with consensus statements
  7. (2005). A systematic review of psychological interventions for the treatment of nonadherence to fluid-intake restrictions in people receiving hemodialysis",
  8. (1997). Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group", Hypertension,
  9. (2004). Achievement of target blood pressure levels in chronic kidney disease: a salty question?",
  10. (2010). Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data",
  11. (2004). Angiotensin-converting-enzyme inhibition in stable coronary artery disease", N.Engl.J.Med.,
  12. Ansell D,Feest T,Hodsman A,and Rao,R 2006, The UK Renal Registry (ninth annual report), The Renal Association.
  13. (2002). Antithrombotic Trilaists' Collaboration
  14. (1996). Assessing the quality of reports of randomized clinical trials: is blinding necessary?",
  15. (2000). Assessment of physical activity: an international perspective",
  16. (2005). Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis", N.Engl.J.Med.,
  17. (2002). Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency",
  18. (2009). Blood pressure (BP) control in multiethnic chronic kidney disease (CKD) population: cross-sectional study".
  19. (2007). Blood pressure (BP) in renal transplant recipients: Are there independent predictors for achieving BP target?” The British Transplantation Society (10thAnnual Congress),
  20. (1996). Blood pressure and end-stage renal disease in men", N.Engl.J.Med.,
  21. (2006). Blood pressure control in patients with chronic renal insufficiency in Spain: a crosssectional study",
  22. (2005). Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial",
  23. (2010). Byrne PhD Thesis,
  24. (2001). Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study",
  25. (2005). Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: a national Veterans Administration study",
  26. (2005). Caring for Australasians with Renal Impairment.
  27. (2001). Chronic disease self-management program: 2-year health status and health care utilization outcomes",
  28. (2007). Chronic kidney Jo Byrne PhD Thesis,
  29. (2001). Client education in the nephrology setting",
  30. (2007). Clinical Practice Guidelines: Chronic kidney disease. http://www.renal.org .
  31. (2002). Clinical practice. Nondiabetic kidney disease",
  32. (2004). Combination therapy improves survival after acute myocardial Jo Byrne PhD Thesis,
  33. (2005). Control of hypertension in adults with chronic kidney disease in the United States", Hypertension,
  34. (2008). Developing and evaluating complex interventions: the new Medical Research Council guidance",
  35. (2005). Development of a questionnaire to measure heart disease risk knowledge in people with diabetes: the Heart Disease Fact Questionnaire",
  36. Diabetes Study Group 1998a, "Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes:
  37. Diabetes Study Group 1998b, "Tight blood pressure control and risk of macrovascular and microvascular complications
  38. (2010). Disease variations in Asians in Leicester",
  39. (2008). Educational interventions in kidney disease care: a systematic review of randomized trials",
  40. (2008). Effect of a multifactorial intervention on mortality in type 2 diabetes",
  41. (2001). Effect of a self-management program on patients with chronic disease",
  42. (2002). Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials",
  43. (1984). Effect of an algorithm and patient information on serum phosphorus levels",
  44. (2002). Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial",
  45. (1995). Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients.
  46. (1997). Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria",
  47. (2010). Effectiveness of a social work psychoeducational program in improving adherence behavior associated with risk of CKD in ESRD patients.
  48. (2008). Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial",
  49. (1992). Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men",
  50. (2001). Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials",
  51. (2005). Effects of an adaptation training programme for patients with end- stage renal disease",
  52. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators",
  53. (2001). Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial",
  54. (1995). Effects of intensification of antihypertensive care in diabetic nephropathy",
  55. (1998). Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) Jo Byrne PhD Thesis,
  56. (1994). Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP)",
  57. (1994). Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients",
  58. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy",
  59. (1999). Effects of psychosocial education on adaptation in elderly hemodialysis patients",
  60. (2008). Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials",
  61. (1997). Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II.",
  62. (2006). Efficacy and safety of benazepril for advanced chronic renal insufficiency", N.Engl.J.Med.,
  63. (1989). Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril",
  64. (2003). Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)",
  65. (2004). Empowerment and self-management of diabetes",
  66. (2004). Empowerment of patients with end-stage renal disease--a randomized controlled trial", -
  67. (1991). Empowerment: an idea whose time has come in diabetes education",
  68. (2003). End-stage renal disease in Indo-Asians in the North-West of England",
  69. (2010). Evaluation and management of the patient with difficult-to-control or resistant hypertension",
  70. (1994). Evaluation of a hemodialysis patient education and support program",
  71. (1982). Evaluation of an experimental education program for new dialysis patients",
  72. (1999). Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial",
  73. (2009). Examining the effectiveness of a peer-led education programme for Type 2 diabetes and cardiovascular disease in a Bangladeshi population",
  74. (2006). Expert Patients Programme: Progress Report
  75. (2000). Framework for design and evaluation of Jo Byrne PhD Thesis,
  76. (1993). Glomerular filtration rate measurements in clinical trials.
  77. (2005). Group based training for self-management strategies in people with type 2 diabetes mellitus",
  78. (2004). Guidelines for management of Jo Byrne PhD Thesis,
  79. Health 2005b, The National Service Framework for Renal Services - Part 2: Chronic Kidney Disease, Acute Renal Failure and End of Life Care
  80. (2004). Health promotion by social cognitive means",
  81. (2000). Health promotion from the perspective of social cognitive theory.," in Understanding and changing health behaviour: From health beliefs to self-regulation,
  82. (2010). High incidence of end-stage renal disease in Indo-Asians in the UK",
  83. (1991). How soon after quitting smoking does risk of heart attack decline?",
  84. (2009). Impact of treating the metabolic syndrome on chronic kidney disease",
  85. (1999). Improving treatment effectiveness in hypertension",
  86. (1992). Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom",
  87. (1999). Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.[see comment]",
  88. (2010). Intervention strategies to improve compliance with medical regimens by ambulatory hemodialysis patients", -
  89. (2005). Interventions used to improve control of blood pressure in patients with hypertension",
  90. (2009). Is there a role for direct renin inhibitors in chronic kidney disease?",
  91. (2001). Issues in hypertension: drug tolerability and special populations",
  92. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification",
  93. (2004). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease",
  94. (1984). Learning in groups Croom Helm,
  95. (1993). Live and learn: patient education delays the need to initiate renal replacement therapy in endstage renal disease",
  96. (2000). Long-term knowledge retention following predialysis psychoeducational intervention",
  97. (2000). Longterm effects of weight loss and dietary sodium reduction on incidence of hypertension",
  98. (2005). Management of hypertension in patients with CKD: differences between primary and tertiary care settings",
  99. (2008). Mechanisms and treatment of resistant hypertension",
  100. (2005). Meta-analysis: chronic disease selfmanagement programs for older adults",
  101. (2004). Metaanalysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes",
  102. (2002). Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressureindependent effect",
  103. (1987). Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition",
  104. (1994). Mortality in relation to smoking: 40 years' observations on male British doctors",
  105. (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial",
  106. (2000). National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence",
  107. (2009). NHS Health Checks. Available from http://www.dh.gov.uk.
  108. of Clinical Excellence 2003, Guidance on the use of patient education models for diabetes,
  109. (2001). Office for National Statistics. Census. http://www.statistics.gov.uk .
  110. (2005). Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia",
  111. (2010). Page 180 National Collaborating Centre for Chronic Conditions [NICE]
  112. (2002). Patient selfmanagement of chronic disease in primary care",
  113. (2007). Patients with resistant hypertension",
  114. (2003). Patients' experiences and opinions of home blood pressure measurement",
  115. (2005). Peer mentoring: a culturally sensitive approach to end-of-life planning for longterm dialysis patients", -
  116. (1992). Perceived self-efficacy in self-management of chronic disease.,"
  117. (2010). PhD Thesis,
  118. (1993). Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men",
  119. (1994). Population need for renal replacement therapy in Thames regions: ethnic dimension",
  120. (2003). Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease", -
  121. (2005). Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up", -
  122. (2000). Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group",
  123. (2001). Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey
  124. (1996). Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group",
  125. (2001). Prevalence of hypertension in renal disease",
  126. (2007). Prevalence, management and control of hypertension in people with chronic kidney (CKD) and diabetes in a multi-ethnic population", Diabetes UK.
  127. Prevention Evaluation Study Investigators 2000, "Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy.",
  128. (2008). Primary carebased disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes",
  129. (2002). Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program",
  130. (1989). Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group",
  131. (2000). Progress in blood pressure control in autosomal dominant polycystic kidney disease",
  132. (2003). Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis",
  133. (2000). Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials",
  134. (2005). Psycho-educational strategies to promote fluid adherence in adult hemodialysis patients: a review of intervention studies",
  135. (1978). Psychometric theory McGraw-Hill,
  136. (2000). Qualitative research in health care. Analysing qualitative data",
  137. (2010). Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease",
  138. (2009). Renal Association Website. The stages of CKD in the CKD eGuide [online]. http://www.renal.org .
  139. (2006). Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial",
  140. (2001). Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study",
  141. (2007). Renal function and outcomes in acute coronary syndrome: impact of clopidogrel",
  142. (1992). Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects.
  143. (2001). Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes", N.Engl.J.Med.,
  144. (1999). Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria",
  145. (2009). Resistant hypertension in the elderly",
  146. (2005). Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary",
  147. (1999). Saving Lives: Our Healthier Nation.'
  148. (2008). Scottish Intercollegiate Guidelines Network.
  149. (2003). Self-efficacy training for patients with end-stage renal disease",
  150. (1997). Self-efficacy: The exercise of control.
  151. (1977). Self-efficacy: toward a unifying theory of behavioral change",
  152. (2004). Self-management education programs in chronic disease: a systematic review and methodological critique of the literature",
  153. (2003). Self-management education: history, definition, outcomes, and mechanisms",
  154. (2004). Simulation model of renal replacement therapy: predicting future demand in England",
  155. (2002). Smoking and the kidney",
  156. (2006). South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients",
  157. Speciality Committee on Renal Medicine 2006, Chronic kidney disease in adults: UK guidelines for identification, management and referral,
  158. (2006). Structured patient education: the diabetes X-PERT Programme makes a difference",
  159. (2002). Successful blood pressure control in the African American Study of Kidney Disease and Hypertension",
  160. Survival Study (4S) 1994, "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)",
  161. (2000). The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability",
  162. (2009). The American Society of Nephrology, Renal Week
  163. (2004). The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease",
  164. (1990). The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects",
  165. (1980). The common-sense representation of illness danger,"
  166. (2001). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials",
  167. (2005). The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet Jo Byrne PhD Thesis,
  168. (1998). The effect of a self-monitoring tool on self-efficacy, health beliefs, and adherence in patients receiving hemodialysis", -
  169. (1993). The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group",
  170. (2004). The effect of diet education on the laboratory values and knowledge of hemodialysis patients with hyperphosphatemia", -
  171. (2001). The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes",
  172. (1989). The effects of behavioral intervention with patients, nurses, and family members on dietary noncompliance in chronic hemodialysis patients",
  173. (1994). The effects of dietary protein restriction and bloodpressure control on the progression of chronic renal disease.
  174. (2001). The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century UK.
  175. (1987). The heuristic model of persuasion," in Social influence: The Ontario
  176. (2005). The impact of education on chronic kidney disease patients' plans to initiate dialysis with self-care dialysis: a randomized trial",
  177. (2000). The life readiness program: a physical di Studi Epidemiologici in Nefrologia)",
  178. (1992). The patient's view of hypertension and compliance",
  179. (1996). The role of social cognition models in predicting health behaviours: future directions.,"
  180. (2002). The use of combination drug therapy in the treatment of hypertension",
  181. (2000). The well-being questionnaire: evidence for a three-factor structure with 12 items (W-BQ12)",
  182. (1996). This paper was also chosen for abstraction and expert commentary in the following journal: Evid Based Nurs
  183. (2005). Understanding of blood pressure by people with type 2 diabetes: a primary care focus group study",
  184. (2008). Waist circumference and visceral fat in CKD: a cross-sectional study",
  185. (2008). Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD",
  186. (1999). What influences a patient's desire to participate in the management of their hypertension?",
  187. (1999). Why don't physicians follow clinical practice guidelines? A framework for improvement",
  188. (2004). Why ethnic minority groups are under-represented in clinical trials: a review of the literature",
  189. (2004). Why hypertensive patients do not comply with the treatment: results from a qualitative study",

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.